Literature DB >> 32011527

Intratumoral Fibrosis and Tumor Growth Pattern as Prognostic Factors in Optimally Resected Pancreatic Neuroendocrine Neoplasms: An Analysis of 168 Cases.

Deyali Chatterjee1, Nikolaos A Trikalinos2, Greg A Williams3, Jingxia Liu3, William G Hawkins3, Chet Hammill3.   

Abstract

OBJECTIVES: Pancreatic neuroendocrine neoplasms (PanNENs) can recur after curative resection. We sought to establish the significance of tumor fibrosis and tumor growth pattern as predictors of recurrence-free survival and overall survival.
METHODS: A retrospective query of an institutional surgical database was performed from 2000 to 2018 to identify optimally resected PanNENs. All eligible slides were reviewed by an experienced gastrointestinal pathologist for established histopathologic prognostic factors, as well as fibrosis and tumor growth pattern. We evaluated the effect of the interested variables through Cox proportional hazards models.
RESULTS: One hundred sixty-eight cases were considered. The majority of patients (90%) had grade 1 or 2 tumors, 46% showed significant fibrosis, and 22% demonstrated an infiltrative growth pattern. Twenty-one percent of patients had a recurrence. In multivariable analysis, lymphovascular invasion with a hazard ratio (HR) of 5.1 and infiltrative growth pattern (HR, 2.8) were significantly associated with increased risk of recurrence and increased risk of death (HR, 3.6 and 2.7, respectively). There was a significant decrease in recurrence-free survival and overall survival for fibrosis and infiltrative growth pattern.
CONCLUSIONS: In optimally resected PanNENs, the presence of fibrosis and infiltrative growth pattern are significant risk factors for recurrence and/or decreased survival.

Entities:  

Mesh:

Year:  2020        PMID: 32011527      PMCID: PMC7021221          DOI: 10.1097/MPA.0000000000001478

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.243


  35 in total

1.  Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate.

Authors:  Esther I van Vliet; Casper H van Eijck; Ronald R de Krijger; Elisabeth J Nieveen van Dijkum; Jaap J Teunissen; Boen L Kam; Wouter W de Herder; Richard A Feelders; Bert A Bonsing; Tessa Brabander; Eric P Krenning; Dik J Kwekkeboom
Journal:  J Nucl Med       Date:  2015-08-13       Impact factor: 10.057

2.  FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.

Authors:  Thierry Conroy; Pascal Hammel; Mohamed Hebbar; Meher Ben Abdelghani; Alice C Wei; Jean-Luc Raoul; Laurence Choné; Eric Francois; Pascal Artru; James J Biagi; Thierry Lecomte; Eric Assenat; Roger Faroux; Marc Ychou; Julien Volet; Alain Sauvanet; Gilles Breysacher; Frédéric Di Fiore; Christine Cripps; Petr Kavan; Patrick Texereau; Karine Bouhier-Leporrier; Faiza Khemissa-Akouz; Jean-Louis Legoux; Béata Juzyna; Sophie Gourgou; Christopher J O'Callaghan; Claire Jouffroy-Zeller; Patrick Rat; David Malka; Florence Castan; Jean-Baptiste Bachet
Journal:  N Engl J Med       Date:  2018-12-20       Impact factor: 91.245

3.  Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression.

Authors:  Wanxing Duan; Ke Chen; Zhengdong Jiang; Xin Chen; Liankang Sun; Jiahui Li; Jianjun Lei; Qinhong Xu; Jiguang Ma; Xuqi Li; Liang Han; Zheng Wang; Zheng Wu; Fengfei Wang; Erxi Wu; Qingyong Ma; Zhenhua Ma
Journal:  Cancer Lett       Date:  2016-10-20       Impact factor: 8.679

4.  Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer.

Authors:  Daoxiang Zhang; Lin Li; Hongmei Jiang; Qiong Li; Andrea Wang-Gillam; Jinsheng Yu; Richard Head; Jingxia Liu; Marianna B Ruzinova; Kian-Huat Lim
Journal:  Cancer Res       Date:  2018-01-23       Impact factor: 12.701

5.  Prognostic significance of tumour infiltration growth pattern in patients with advanced gastric cancer.

Authors:  Bochao Zhao; Jiale Zhang; Di Mei; Xinyu Huang; Shihui Zou; Rui Luo; Huimian Xu; Baojun Huang
Journal:  J Clin Pathol       Date:  2018-11-22       Impact factor: 3.411

6.  HALO-109-301: a Phase III trial of PEGPH20 (with gemcitabine and nab-paclitaxel) in hyaluronic acid-high stage IV pancreatic cancer.

Authors:  Gary J Doherty; Margaret Tempero; Pippa G Corrie
Journal:  Future Oncol       Date:  2017-10-23       Impact factor: 3.404

7.  Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.

Authors:  Axel Grothey; Alberto F Sobrero; Anthony F Shields; Takayuki Yoshino; James Paul; Julien Taieb; John Souglakos; Qian Shi; Rachel Kerr; Roberto Labianca; Jeffrey A Meyerhardt; Dewi Vernerey; Takeharu Yamanaka; Ioannis Boukovinas; Jeffrey P Meyers; Lindsay A Renfro; Donna Niedzwiecki; Toshiaki Watanabe; Valter Torri; Mark Saunders; Daniel J Sargent; Thierry Andre; Timothy Iveson
Journal:  N Engl J Med       Date:  2018-03-29       Impact factor: 91.245

8.  Everolimus for advanced pancreatic neuroendocrine tumors.

Authors:  James C Yao; Manisha H Shah; Tetsuhide Ito; Catherine Lombard Bohas; Edward M Wolin; Eric Van Cutsem; Timothy J Hobday; Takuji Okusaka; Jaume Capdevila; Elisabeth G E de Vries; Paola Tomassetti; Marianne E Pavel; Sakina Hoosen; Tomas Haas; Jeremie Lincy; David Lebwohl; Kjell Öberg
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

9.  Lymph nodes and survival in pancreatic neuroendocrine tumors.

Authors:  Geoffrey W Krampitz; Jeffrey A Norton; George A Poultsides; Brendan C Visser; Lixian Sun; Robert T Jensen
Journal:  Arch Surg       Date:  2012-09

10.  Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor.

Authors:  Heli Gao; Liang Liu; Wenquan Wang; Huaxiang Xu; Kaizhou Jin; Chuntao Wu; Zihao Qi; Shirong Zhang; Chen Liu; Jinzhi Xu; Quanxing Ni; Xianjun Yu
Journal:  Cancer Lett       Date:  2017-10-26       Impact factor: 8.679

View more
  2 in total

1.  Qualitative imaging features of pancreatic neuroendocrine neoplasms predict histopathologic characteristics including tumor grade and patient outcome.

Authors:  Motoyo Yano; Anup S Shetty; Greg A Williams; Samantha Lancia; Nikolaos A Trikalinos; Chet W Hammill; William G Hawkins; Amber Salter; Deyali Chatterjee
Journal:  Abdom Radiol (NY)       Date:  2022-02-15

2.  Infiltration pattern predicts metastasis and progression better than the T-stage and grade in pancreatic neuroendocrine tumors: a proposal for a novel infiltration-based morphologic grading.

Authors:  Orhun Cig Taskin; Michelle D Reid; Pelin Bagci; Serdar Balci; Ayse Armutlu; Deniz Demirtas; Burcin Pehlivanoglu; Burcu Saka; Bahar Memis; Emine Bozkurtlar; Can Berk Leblebici; Adelina Birceanu; Yue Xue; Mert Erkan; Yersu Kapran; Arzu Baygul; Cenk Sokmensuer; Aldo Scarpa; Claudio Luchini; Olca Basturk; Volkan Adsay
Journal:  Mod Pathol       Date:  2021-12-30       Impact factor: 7.842

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.